Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Buy
51
HSTM Quote, Financials, Valuation and Earnings
Last price:
$31.56
Seasonality move
:
13.55%
Day range:
$30.94 - $32.13
52-week range:
$23.92 - $34.24
Dividend yield:
0.37%
P/E ratio:
47.80x
P/S ratio:
3.30x
P/B ratio:
2.67x
Volume:
473.7K
Avg. volume:
183K
1-year change:
18.61%
Market cap:
$960.2M
Revenue:
$291.6M
EPS (TTM):
$0.66
Analysts' Opinion
-
Consensus RatingHealthStream has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $35.00, HealthStream has an estimated upside of 10.94% from its current price of $31.55.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $30.00 representing 100% downside risk from its current price of $31.55.
Fair Value
-
According to the consensus of 6 analysts, HealthStream has 10.94% upside to fair value with a price target of $35.00 per share.
HSTM vs. S&P 500
-
Over the past 5 trading days, HealthStream has overperformed the S&P 500 by 1.07% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
HealthStream does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HealthStream has grown year-over-year revenues for 16 quarters straight. In the most recent quarter HealthStream reported revenues of $74.2M.
Earnings Growth
-
HealthStream has grown year-over-year earnings for 7 quarters straight. In the most recent quarter HealthStream reported earnings per share of $0.16.
Enterprise value:
863M
EV / Invested capital:
2.40x
Price / LTM sales:
3.30x
EV / EBIT:
40.54x
EV / Revenue:
2.96x
PEG ratio (5yr expected):
1.49x
EV / Free cash flow:
29.24x
Price / Operating cash flow:
32.65x
Enterprise value / EBITDA:
13.80x
Gross Profit (TTM):
$193.7M
Return On Assets:
3.96%
Net Income Margin (TTM):
6.86%
Return On Equity:
5.72%
Return On Invested Capital:
5.72%
Operating Margin:
6.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $266.8M | $279.1M | $291.6M | $70.6M | $74.2M | |
| Gross Profit | $175.7M | $184M | $193.7M | $46.6M | $49.1M | |
| Operating Income | $12.4M | $16M | $21.3M | $4.3M | $4.7M | |
| EBITDA | $50.4M | $57.1M | $62.5M | $14.8M | $15.2M | |
| Diluted EPS | $0.39 | $0.50 | $0.66 | $0.15 | $0.16 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $114.7M | $106.8M | $114.4M | $130.2M | $153.1M | |
| Total Assets | $500.3M | $486.8M | $497.7M | $499.9M | $510.8M | |
| Current Liabilities | $119.4M | $100.4M | $117.2M | $118.4M | $115.7M | |
| Total Liabilities | $166.3M | $147.7M | $163.7M | $159.2M | $151.4M | |
| Total Equity | $334.1M | $339M | $334.1M | $340.8M | $359.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $51.2M | $64M | $57.7M | $13.8M | $11.2M | |
| Cash From Investing | -$28.4M | -$56.6M | -$34M | -$9.4M | -$8.1M | |
| Cash From Financing | -$23.7M | -$13M | -$4.5M | -$8.3M | -$1M | |
| Free Cash Flow | $26.1M | $36M | $29.5M | $7.2M | $4.3M | |
HSTM
Sector
Market Cap
$960.2M
$39.2M
Price % of 52-Week High
92.14%
45.93%
Dividend Yield
0.37%
0%
Shareholder Yield
--
-0.81%
1-Year Price Total Return
18.61%
-38.63%
Beta (5-Year)
0.374
0.774
Dividend yield:
0.37%
Annualized payout:
$0.11
Payout ratio:
17.01%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$31.43
200-day SMA
Buy
Level
$30.26
Bollinger Bands (100)
Sell
Level
30.76 - 33.28
Chaikin Money Flow
Buy
Level
15.2M
20-day SMA
Sell
Level
$32.35
Relative Strength Index (RSI14)
Sell
Level
43.26
ADX Line
Sell
Level
32.34
Williams %R
Neutral
Level
-67.3768
50-day SMA
Sell
Level
$32.52
MACD (12, 26)
Sell
Level
-0.42
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
23.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.93)
Buy
CA Score
(Annual)
Level (0.8358)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.353)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
Stock Forecast FAQ
In the current month, HSTM has received 2 Buy ratings 4 Hold ratings, and 0 Sell ratings. The HSTM average analyst price target in the past 3 months is $35.00.
-
Where Will HealthStream Stock Be In 1 Year?
According to analysts, the consensus estimate is that HealthStream share price will rise to $35.00 per share over the next 12 months.
-
What Do Analysts Say About HealthStream?
Analysts are divided on their view about HealthStream share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthStream is a Sell and believe this share price will drop from its current level to $30.00.
-
What Is HealthStream's Price Target?
The price target for HealthStream over the next 1-year time period is forecast to be $35.00 according to 6 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is HSTM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HealthStream is a Hold. 4 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HSTM?
You can purchase shares of HealthStream via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthStream shares.
-
What Is The HealthStream Share Price Today?
HealthStream was last trading at $31.56 per share. This represents the most recent stock quote for HealthStream. Yesterday, HealthStream closed at $31.55 per share.
-
How To Buy HealthStream Stock Online?
In order to purchase HealthStream stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
